Barchart on MSN3d
Catalent Stock: Analyst Estimates & RatingsWith a market cap of $10.7 billion, Catalent, Inc. (CTLT) is a leading global provider of advanced delivery technologies and ...
Baird has recently raised Catalent Inc (CTLT) stock to Outperform rating, as announced on November 16, 2023, according to Finviz. Earlier, on September 5, 2023, Argus had raised the stock from a Hold ...
CTLT's solid segmental results led to an encouraging fiscal first-quarter performance, driving share prices in after-hours trading. The company provides filling and packaging services for syringes ...
CIBC Asset Management Inc grew its holdings in shares of Catalent, Inc. (NYSE:CTLT – Free Report) by 7.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities ...
Catalent (NYSE:CTLT) rose 2% amid a report that the European Union's antitrust regulator will likely grant approval for its ...
There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.
Investors interested in Medical - Drugs stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and Catalent (CTLT). But which of these two stocks is more attractive to value investors?
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback